TY - JOUR
T1 - FOXO1 cooperates with C/EBPδ and ATF4 to regulate skeletal muscle atrophy transcriptional program during fasting
AU - Oyabu, Mamoru
AU - Takigawa, Kaho
AU - Mizutani, Sako
AU - Hatazawa, Yukino
AU - Fujita, Mariko
AU - Ohira, Yuto
AU - Sugimoto, Takumi
AU - Suzuki, Osamu
AU - Tsuchiya, Kyoichiro
AU - Suganami, Takayoshi
AU - Ogawa, Yoshihiro
AU - Ishihara, Kengo
AU - Miura, Shinji
AU - Kamei, Yasutomi
N1 - Funding Information:
We thank Dr. Ayaka Ito (Nagoya University) for her advice on statistical analysis, and Dr. Yusuke Ono (Kumamoto University) for discussion. Microarray data analysis was, in part, performed at the Medical Research Support Center, Graduate School of Medicine, Kyoto University. This study is supported by grants‐in‐aid for scientific research (KAKENHI) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT, Tokyo). This study is also supported by The Fuji Foundation for Protein Research and by The Tojuro Iijima Foundation for Food Science and Technology. The funders had no role in study design, data collection and analysis, the decision to publish, and preparation of the manuscript.
Funding Information:
We thank Dr. Ayaka Ito (Nagoya University) for her advice on statistical analysis, and Dr. Yusuke Ono (Kumamoto University) for discussion. Microarray data analysis was, in part, performed at the Medical Research Support Center, Graduate School of Medicine, Kyoto University. This study is supported by grants-in-aid for scientific research (KAKENHI) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT, Tokyo). This study is also supported by The Fuji Foundation for Protein Research and by The Tojuro Iijima Foundation for Food Science and Technology. The funders had no role in study design, data collection and analysis, the decision to publish, and preparation of the manuscript.
Publisher Copyright:
© 2022 Federation of American Societies for Experimental Biology
PY - 2022/2
Y1 - 2022/2
N2 - Catabolic conditions, such as starvation, inactivity, and cancer cachexia, induce Forkhead box O (FOXO) transcription factor(s) expression and severe muscle atrophy via the induction of ubiquitin–proteasome system-mediated muscle proteolysis, resulting in frailty and poor quality of life. Although FOXOs are clearly essential for the induction of muscle atrophy, it is unclear whether there are other factors involved in the FOXO-mediated transcriptional regulation. As such, we identified FOXO–CCAAT/enhancer-binding protein δ (C/EBPδ) signaling pathway as a novel proteolytic pathway. By comparing the gene expression profiles of FOXO1-transgenic (gain-of-function model) and FOXO1,3a,4–/– (loss-of-function model) mice, we identified several novel FOXO1-target genes in skeletal muscle including Redd1, Sestrin1, Castor2, Chac1, Depp1, Lat3, as well as C/EBPδ. During starvation, C/EBPδ abundance was increased in a FOXOs-dependent manner. Notably, knockdown of C/EBPδ prevented the induction of the ubiquitin–proteasome system and decrease of myofibers in FOXO1-activated myotubes. Conversely, C/EBPδ overexpression in primary myotubes induced myotube atrophy. Furthermore, we demonstrated that FOXO1 enhances the promoter activity of target genes in cooperation with C/EBPδ and ATF4. This research comprehensively identifies novel FOXO1 target genes in skeletal muscle and clarifies the pathophysiological role of FOXO1, a master regulator of skeletal muscle atrophy.
AB - Catabolic conditions, such as starvation, inactivity, and cancer cachexia, induce Forkhead box O (FOXO) transcription factor(s) expression and severe muscle atrophy via the induction of ubiquitin–proteasome system-mediated muscle proteolysis, resulting in frailty and poor quality of life. Although FOXOs are clearly essential for the induction of muscle atrophy, it is unclear whether there are other factors involved in the FOXO-mediated transcriptional regulation. As such, we identified FOXO–CCAAT/enhancer-binding protein δ (C/EBPδ) signaling pathway as a novel proteolytic pathway. By comparing the gene expression profiles of FOXO1-transgenic (gain-of-function model) and FOXO1,3a,4–/– (loss-of-function model) mice, we identified several novel FOXO1-target genes in skeletal muscle including Redd1, Sestrin1, Castor2, Chac1, Depp1, Lat3, as well as C/EBPδ. During starvation, C/EBPδ abundance was increased in a FOXOs-dependent manner. Notably, knockdown of C/EBPδ prevented the induction of the ubiquitin–proteasome system and decrease of myofibers in FOXO1-activated myotubes. Conversely, C/EBPδ overexpression in primary myotubes induced myotube atrophy. Furthermore, we demonstrated that FOXO1 enhances the promoter activity of target genes in cooperation with C/EBPδ and ATF4. This research comprehensively identifies novel FOXO1 target genes in skeletal muscle and clarifies the pathophysiological role of FOXO1, a master regulator of skeletal muscle atrophy.
UR - http://www.scopus.com/inward/record.url?scp=85123653894&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123653894&partnerID=8YFLogxK
U2 - 10.1096/fj.202101385RR
DO - 10.1096/fj.202101385RR
M3 - Article
C2 - 35061305
AN - SCOPUS:85123653894
VL - 36
JO - FASEB Journal
JF - FASEB Journal
SN - 0892-6638
IS - 2
M1 - e22152
ER -